26.11.2012
- An experimental vaccine based on a molecule related to DNA protects animals against influenza and may one day offer an ultra-rapid way to develop new shots for humans, German...
15.10.2012
- Biotech company ExpreS2ion Biotechnologies today announced that they have signed a research license agreement to provide the University of Oxford access to ExpreS2ion's Drosophila...
18.09.2012
- Billionaire German investor Dietmar Hopp is betting another €80 million ($105 million) on CureVac, a pioneer of vaccines based on a molecule related to DNA, in one of the biggest...
15.03.2012
- The Swiss Chemical Society has awarded the "Sandmeyer Award 2012 - sponsored by KPMG" to a research team from Solvias. Working for Sanofi Pasteur, the team developed an innovative...
27.01.2012
- The production of pharmaceutical products requires strict compliance with specified ambient conditions. Since the building automation systems (BAS) must meet very special...
27.09.2011
- Inovio Pharmaceuticals Tuesday reported inking a Cooperative Research and Development Agreement, or CRADA, with the United States Department of Homeland Security's, or DHS's...
21.09.2011
- Sanofi Pasteur, the vaccines division of Sanofi-Aventis, announced a research and development collaboration with the University of California, San Diego on an immunological...
08.12.2010
- U.S. healthcare group Johnson & Johnson made a long-awaited €1.75 billion bid for Crucell on Wednesday, shrugging off the Dutch biotech company's recent problems with vaccine...
